Instalab
logoInstalab

Desulfobacterota_A

Stool Test
Get an exploratory view of gut bacteria involved in sulfur processing and bowel-health research.
4.9 (3,197 reviews)
Tested by Genova Diagnostics
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped directly to you
Get results
Explained with clear next steps, no medical jargon

Should you take a Desulfobacterota_A test?

This test is most useful if any of these apply to you.

Looking Into Recurring Gut Symptoms
You want exploratory information about your gut bacteria while evaluating persistent symptoms with established tests.
Curious About Your Gut Bacteria
You want a snapshot of this bacterial group and understand that its abundance has no established health target.
Concerned About a Family History of Colon Cancer
You're curious about microbiome research while keeping screening based on your family history.
Living With Colitis or Crohn's
You want exploratory community data alongside established disease monitoring; this result does not measure a flare.

About Desulfobacterota_A

Desulfobacterota_A includes bacteria that can produce hydrogen sulfide in your gut. This gas gives rotten eggs their smell. The stool result estimates the share of your microbial community assigned to this bacterial group; it doesn't measure how much gas is being produced or whether your colon lining is being injured.

This is a research-stage marker. Its abundance has no established healthy target, and using it to predict disease or guide treatment has not been shown to improve health outcomes. Most human evidence concerns a broader bacterial group, an individual species, or a diet associated with sulfur-processing bacteria.

A Branch of the Gut's Sulfur-Processing Community

The name comes from the Genome Taxonomy Database, which classifies bacteria by comparing their genomes. Desulfobacterota_A is a phylum-level lineage that includes gut bacteria such as Desulfovibrio and Bilophila. The letter distinguishes a branch within this classification system.

These bacteria don't all handle sulfur in the same way. Desulfovibrio species can use sulfate during energy production and release hydrogen sulfide. Bilophila wadsworthia can obtain sulfur from taurine and produce sulfide through a different route. Taurine occurs in food and in some bile acids. Experiments with human gut bacteria in mice also show that Desulfovibrio piger can use sulfate released from intestinal mucus by other bacteria.

Laboratory experiments explain why sulfide attracts attention. In cultured human colon cells, high sulfide exposure inhibited the use of butyrate as fuel. Butyrate is a fatty acid made by some gut bacteria when they break down fiber. Other experiments in rodents found protective effects of sulfide during colitis. These findings show that its effects depend on the conditions; they don't establish a harmful Desulfobacterota_A percentage in human stool.

Related sulfate-reducing bacteria also occur in healthy people. A small study using targeted DNA measurement found different amounts of Desulfovibrio in infants, young adults, and older adults. That was a measurement of one genus, not the relative abundance of this entire lineage, and it doesn't establish an age-specific target.

Colorectal Cancer

One influential study used repeated stool samples from 307 men to identify a community of 43 sulfur-processing species and develop a dietary score associated with that community. The pattern included more processed meat and fewer vegetables and legumes. Researchers then applied the score to dietary records from about 48,000 men followed for 26 years.

Men in the highest quarter of the diet score had 43% higher risk of cancer in the lower colon and rectum than those in the lowest quarter. The study found no clear association with cancer in the upper colon. This was an association with a dietary pattern, not a risk estimate based on each participant's Desulfobacterota_A result.

Studies that measure stool bacteria directly also need careful interpretation. One study across the polyp-to-cancer sequence found an association involving Desulfovibrio that was most consistent in later-stage cancer and depended on the analysis. It did not validate this lineage as an early cancer signal. A bacterial difference after cancer develops can reflect changes caused by the disease.

Diet Scores and Earlier Death

A separate US study developed another sulfur microbial diet score using stool samples from Black adults. In roughly 50,000 Black participants within a larger cohort, those in the highest quarter of this score had about 21% higher risk of death from any cause over about 14 years than those in the lowest quarter. The study reported a similar pattern among White participants. This was a newly developed score, not the same score used in the earlier men's cancer study.

In another analysis of about 92,000 participants in a US cancer screening study, the highest sulfur microbial diet scores were associated with about 12% higher risk of death from any cause and 15% higher risk of cancer death over a median of 15 years. Diet was not randomly assigned. These analyses cannot establish that sulfur-processing bacteria caused the differences or that changing this stool result would change your risk.

Inflammatory Bowel Disease

An early stool culture study detected Desulfovibrio piger in 55% of people with inflammatory bowel disease and 12% of healthy participants. The inflammatory bowel disease group was small. Total sulfate-reducing bacterial counts did not distinguish the clinical groups. Detecting one species by culture is a different measurement from sequencing the relative abundance of Desulfobacterota_A.

A later stool sequencing study found that the broader Desulfobacterota group was less abundant in people with ulcerative colitis, both during active disease and in remission, than in healthy controls. Different species, methods, and populations can produce different findings. Neither study establishes that a high result means inflammation or that a low result identifies a flare.

Blood Sugar and Eye Disease

In a study of 279 Spanish adults with overweight or obesity and no diabetes, greater insulin resistance was associated with less stool Desulfovibrio. Insulin resistance means your cells respond less effectively to insulin. This was a single-time-point association with one genus.

A separate study of 50 adults found more of the broader Desulfobacterota group in people with diabetic retinopathy than in healthy controls. Diabetic retinopathy is damage to the eye's small blood vessels caused by diabetes. The study lacked a comparison group with diabetes but no retinopathy, so it couldn't separate an association with diabetes from one specific to eye damage.

A 22-person pilot study also suggested a difference in the related Desulfovibrionales order in advanced age-related macular degeneration. These small studies measured different bacterial groupings. They don't support using Desulfobacterota_A to assess insulin resistance, predict eye disease, or decide whether increasing or decreasing the result would help.

Gum Disease

A small observational study found more stool Desulfovibrio fairfieldensis in people with severe molar-incisor pattern periodontitis than in healthy controls. This is a form of gum disease that can begin early in life. The finding concerns one related species, and it doesn't establish that this stool lineage causes gum disease or can be used to monitor dental treatment.

When Results Can Be Misleading

This result comes from whole-genome sequencing of stool DNA and is reported as relative abundance. A larger percentage can occur because this group increased, because other organisms decreased, or both. The result does not establish an absolute bacterial count or the amount of sulfide reaching your gut lining.

  • Collection and stool consistency: contamination, storage conditions, and differences between hard and loose stools can affect the community represented in a sample.
  • Sequencing and classification: DNA extraction, sequencing depth, and reference databases affect which organisms are detected and how they are grouped. Rare organisms may be missed, and database updates can change names or assignments.
  • Recent antibiotics and other medicines: antibiotics can alter the stool community for months, with recovery differing by drug and person. Acid-suppressing medicines can also affect community composition. These findings do not establish a predictable response for this particular lineage.
  • Different biological measurements: a whole-lineage percentage, a targeted Desulfovibrio DNA count, and a measurement of sulfide are separate results. They cannot be substituted for one another.
  • Population differences: age, body weight, diet, and disease activity can differ between study groups and influence apparent disease associations.

Changes Over Time

Gut communities contain both persistent organisms and changing proportions. In one year-long study of healthy adults, changes within individuals accounted for about a quarter of the variation in community composition. That finding concerns the whole microbiome. A change in this lineage's percentage can be real without indicating that your health has improved or worsened.

What Moves This Biomarker

Evidence-backed interventions that affect your Desulfobacterota_A level

↓ Decrease
Heat-treated Lactobacillus helveticus CP790-fermented milk daily for four weeks
A randomized trial found a reduction in the broader Desulfobacterota group's relative abundance, with softer stools and less straining than placebo. Desulfobacterota_A was not reported separately. The symptom benefit does not establish that lowering this particular lineage is beneficial.
DietModest Evidence

Frequently Asked Questions

Panels containing Desulfobacterota_A

Desulfobacterota_A is included in these pre-built panels.

References

29 studies
  1. Genome Taxonomy DatabaseGenome Taxonomy Databasen.d.
  2. List of Prokaryotic Names With Standing in NomenclatureLPSNn.d.
  3. Genova DiagnosticsGenova Diagnosticsn.d.
  4. Serena Porcari, Benjamin H. Mullish, Francesco Asnicar, Siew C. Ng, Liping Zhao, Richard Hansen, Et Al.The Lancet Gastroenterology & Hepatology2025
  5. Federico E. Rey, Mark D. Gonzalez, Jiye Cheng, Meng Wu, Philip P. Ahern, Jeffrey I. GordonProceedings of the National Academy of Sciences2013

Desulfobacterota_A Testing Option

Microbiomix

$639

See what your gut microbes are actually doing, not just whether your digestion feels off, and track the balance over time.

Includes 60 biomarkers:
Desulfobacterota_AShannon Diversity IndexHexa-lipopolysaccharide (hexa-LPS) productionMethane productionTrimethylamine production
FSA/HSA eligible
No Rx needed
HIPAA compliant